Zelalem Eshete

Array ( [id] => 5005597 [patent_doc_number] => 20070203169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Isomers and 42-epimers of rapamycin ester analogs, methods of making and using the same' [patent_app_type] => utility [patent_app_number] => 11/364313 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5887 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203169.pdf [firstpage_image] =>[orig_patent_app_number] => 11364313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 609608 [patent_doc_number] => 07151098 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-19 [patent_title] => 'Glutamate receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/363351 [patent_app_country] => US [patent_app_date] => 2006-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41494 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/151/07151098.pdf [firstpage_image] =>[orig_patent_app_number] => 11363351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8214337 [patent_doc_number] => 08193196 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations' [patent_app_type] => utility [patent_app_number] => 11/658702 [patent_app_country] => US [patent_app_date] => 2006-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4285 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193196.pdf [firstpage_image] =>[orig_patent_app_number] => 11658702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5683564 [patent_doc_number] => 20060199834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Oxepane isomer of 42-O-(2-hydroxy)ethyl-rapamycin' [patent_app_type] => utility [patent_app_number] => 11/359166 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4341 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20060199834.pdf [firstpage_image] =>[orig_patent_app_number] => 11359166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7601748 [patent_doc_number] => 07384953 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-10 [patent_title] => 'Purification of rapamycin' [patent_app_type] => utility [patent_app_number] => 11/359294 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2731 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/384/07384953.pdf [firstpage_image] =>[orig_patent_app_number] => 11359294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 404814 [patent_doc_number] => 07288647 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-30 [patent_title] => 'Recovery of CCI-779 from mother liquors' [patent_app_type] => utility [patent_app_number] => 11/359842 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2103 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/288/07288647.pdf [firstpage_image] =>[orig_patent_app_number] => 11359842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705914 [patent_doc_number] => 20060194962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it' [patent_app_type] => utility [patent_app_number] => 11/358954 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1547 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194962.pdf [firstpage_image] =>[orig_patent_app_number] => 11358954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705916 [patent_doc_number] => 20060194964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Gamma d-Crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it' [patent_app_type] => utility [patent_app_number] => 11/359262 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1416 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194964.pdf [firstpage_image] =>[orig_patent_app_number] => 11359262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705915 [patent_doc_number] => 20060194963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Gamma-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it' [patent_app_type] => utility [patent_app_number] => 11/358955 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1499 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194963.pdf [firstpage_image] =>[orig_patent_app_number] => 11358955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705917 [patent_doc_number] => 20060194965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Beta d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it' [patent_app_type] => utility [patent_app_number] => 11/359263 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1374 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194965.pdf [firstpage_image] =>[orig_patent_app_number] => 11359263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656530 [patent_doc_number] => 20060142266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Compounds and their uses' [patent_app_type] => utility [patent_app_number] => 11/357334 [patent_app_country] => US [patent_app_date] => 2006-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 44245 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142266.pdf [firstpage_image] =>[orig_patent_app_number] => 11357334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 471045 [patent_doc_number] => RE039679 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2007-06-05 [patent_title] => 'Substituted heterocycle fused gamma-carbolines' [patent_app_type] => reissue [patent_app_number] => 11/356423 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 206441 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039679.pdf [firstpage_image] =>[orig_patent_app_number] => 11356423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 471047 [patent_doc_number] => RE039680 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2007-06-05 [patent_title] => 'Substituted heterocycle fused gamma-carbolines' [patent_app_type] => reissue [patent_app_number] => 11/356421 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57575 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 742 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039680.pdf [firstpage_image] =>[orig_patent_app_number] => 11356421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4509018 [patent_doc_number] => 07915403 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Production of lactams' [patent_app_type] => utility [patent_app_number] => 11/884883 [patent_app_country] => US [patent_app_date] => 2006-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2284 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915403.pdf [firstpage_image] =>[orig_patent_app_number] => 11884883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 840567 [patent_doc_number] => 07390897 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-24 [patent_title] => 'Method for making caprolactam from impure 6-aminocapronitrile' [patent_app_type] => utility [patent_app_number] => 11/083715 [patent_app_country] => US [patent_app_date] => 2006-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6329 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/390/07390897.pdf [firstpage_image] =>[orig_patent_app_number] => 11083715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 840567 [patent_doc_number] => 07390897 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-24 [patent_title] => 'Method for making caprolactam from impure 6-aminocapronitrile' [patent_app_type] => utility [patent_app_number] => 11/083715 [patent_app_country] => US [patent_app_date] => 2006-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6329 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/390/07390897.pdf [firstpage_image] =>[orig_patent_app_number] => 11083715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760734 [patent_doc_number] => 20060211679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Substituted lactams as inhibitors of Abeta protein production' [patent_app_type] => utility [patent_app_number] => 11/348091 [patent_app_country] => US [patent_app_date] => 2006-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35135 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211679.pdf [firstpage_image] =>[orig_patent_app_number] => 11348091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705737 [patent_doc_number] => 20060194785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/343077 [patent_app_country] => US [patent_app_date] => 2006-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31680 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194785.pdf [firstpage_image] =>[orig_patent_app_number] => 11343077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 585988 [patent_doc_number] => 07442707 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-28 [patent_title] => 'CCI-779 polymorph and use thereof' [patent_app_type] => utility [patent_app_number] => 11/339728 [patent_app_country] => US [patent_app_date] => 2006-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6946 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/442/07442707.pdf [firstpage_image] =>[orig_patent_app_number] => 11339728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652192 [patent_doc_number] => 20080039448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Pyrrolobenzodiazepines' [patent_app_type] => utility [patent_app_number] => 11/336623 [patent_app_country] => US [patent_app_date] => 2006-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4765 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039448.pdf [firstpage_image] =>[orig_patent_app_number] => 11336623 [rel_patent_id] =>[rel_patent_doc_number] =>)